Annual Drug Patent Expirations for EXPAREL
Exparel is a drug marketed by Pacira Pharms Inc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
Drug patent litigation for EXPAREL.
This drug has seven patent family members in four countries.
The generic ingredient in EXPAREL is bupivacaine. One supplier is listed for this compound. Additional details are available on the bupivacaine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
